De Witte T - Search Results

1

Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 years.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: de pauw b. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:33-5. Bone Marrow Transplant. 1989. PMID: 2697396 Clinical Trial.

2

Autologous stem cell transplantation in myelodysplastic syndromes.

de Witte T, Suciu S, Brand R, Muus P, Kröger N. de Witte T, et al. Semin Hematol. 2007 Oct;44(4):274-7. doi: 10.1053/j.seminhematol.2007.08.006. Semin Hematol. 2007. PMID: 17961727 Review.

3

A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients.

Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, DePauw BE. Donnelly JP, et al. Among authors: de witte t. Bone Marrow Transplant. 1992 Jun;9(6):409-13. Bone Marrow Transplant. 1992. PMID: 1628123

4

In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia.

Raymakers R, De Witte T, Joziasse J, Van der Lely N, Boezeman J, Haanen C. Raymakers R, et al. Among authors: de witte t. Br J Haematol. 1991 May;78(1):35-41. doi: 10.1111/j.1365-2141.1991.tb04379.x. Br J Haematol. 1991. PMID: 2043479

5

Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.

De Pauw BE, Donnelly JP, De Witte T, Nováková IR, Schattenberg A. De Pauw BE, et al. Among authors: de witte t. Bone Marrow Transplant. 1990 Mar;5(3):179-82. Bone Marrow Transplant. 1990. PMID: 2184908 Clinical Trial.

6

Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.

Bär BM, de Witte T, de Pauw BE, Haanen C. Bär BM, et al. Among authors: de witte t, de pauw be. Neth J Med. 1990 Feb;36(1-2):19-24. Neth J Med. 1990. PMID: 2314517

7

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: de pauw b. Cancer. 1990 Sep 1;66(5):831-7. doi: 10.1002/1097-0142(19900901)66:5<831::aid-cncr2820660503>3.0.co;2-e. Cancer. 1990. PMID: 2386911

8

Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery.

Van der Lely N, De Witte T, Raemaekers J, Schattenberg A, Haanen C. Van der Lely N, et al. Among authors: de witte t. Bone Marrow Transplant. 1989 Mar;4(2):163-6. Bone Marrow Transplant. 1989. PMID: 2650786

9

Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.

Schattenberg A, De Vries F, De Witte T, Cohen O, Donnelly JP, De Pauw BE. Schattenberg A, et al. Among authors: de vries f, de witte t, de pauw be. Bone Marrow Transplant. 1988 Sep;3(5):509-12. Bone Marrow Transplant. 1988. PMID: 2847845

10

Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.

De Witte T, Awwad B, Boezeman J, Schattenberg A, Muus P, Raemaekers J, Preijers F, Strijckmans P, Haanen C. De Witte T, et al. Bone Marrow Transplant. 1994 Nov;14(5):767-74. Bone Marrow Transplant. 1994. PMID: 7889010 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters